Title:Interplay between mutational pathway and drug gradient controls time to evolution of drug resistance

Abstract:Drug gradients are believed to play an important role in the evolution of drug resistance, from antibiotics to cancer. We use a statistical physics model to study the evolution of a population of malignant cells exposed to drug gradients, where drug resistance emerges via multiple mutations. We show that a non-uniform drug concentration can strongly accelerate the emergence of resistance when the mutational pathway involves a long sequence of mutants with increasing resistance, but slows it down if the pathway is short or crosses a fitness valley. These predictions can be verified experimentally, and have the potential to improve strategies to combat the emergence of resistance.